Effect of 1-methyl-4-phemyl-1,2,3,6-tetrahydropyridine (MPTP) on levels of glutathione in the extrapyramidal system of the mouse
- 1 September 1986
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 25 (9) , 1071-1074
- https://doi.org/10.1016/0028-3908(86)90205-4
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Depletion of glutathione in brainstem of mice caused by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is prevented by antioxidant pretreatmentNeuroscience Letters, 1986
- Permanent human parkinsonism due to 1‐methy 1–4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)Neurology, 1985
- The Regulation of Hepatic GlutathioneAnnual Review of Pharmacology and Toxicology, 1985
- The importance of free radicals and catalytic metal ions in human diseasesMolecular Aspects of Medicine, 1985
- V. Potential bioactivation pathways for the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)Life Sciences, 1985
- Dopaminergic Neurotoxicity of 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine in MiceScience, 1984
- Parkinson's disease: A disorder due to nigral glutathione deficiency?Neuroscience Letters, 1982
- Recent Advances in the Chemistry of Melanogenesis in MammalsJournal of Investigative Dermatology, 1980
- REGIONAL DISTRIBUTION OF AMINO ACIDS IN HUMAN BRAIN OBTAINED AT AUTOPSYJournal of Neurochemistry, 1971